STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 13, 2026, 05:01 PM

IM Cannabis Q1 2026 Revenue $8.7M; Net Loss $2.5M

AI Summary

IM Cannabis Corp. announced its financial results for the first quarter ended March 31, 2026, reporting revenues of $8.7 million and a net loss of $2.5 million, or $0.38 per share. The company continued its cost optimization initiatives, reducing general and administrative expenses by 22% year-over-year. Management remains focused on operational efficiencies, working capital discipline, and evaluating strategic opportunities, supported by convertible note financings completed during and after the quarter.

Key Highlights

  • Q1 2026 revenue was $8.7 million, down from $12.5 million in Q1 2025.
  • Gross profit for Q1 2026 was $1.4 million.
  • Operating loss for Q1 2026 was $1.7 million.
  • Net loss for Q1 2026 was $2.5 million, or $0.38 per share.
  • General and administrative expenses were reduced by 22% year-over-year.
  • Completed convertible note financings during and after the quarter to support liquidity.
IMCC
Medicinal Chemicals and Botanical Products
IM Cannabis Corp.

Price Impact